Cargando…
Amelioration of Diabetic Mouse Nephropathy by Catalpol Correlates with Down-Regulation of Grb10 Expression and Activation of Insulin-Like Growth Factor 1 / Insulin-Like Growth Factor 1 Receptor Signaling
Growth factor receptor-bound protein 10 (Grb10) is an adaptor protein that can negatively regulate the insulin-like growth factor 1 receptor (IGF-1R). The IGF1-1R pathway is critical for cell growth and apoptosis and has been implicated in kidney diseases; however, it is still unknown whether Grb10...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795681/ https://www.ncbi.nlm.nih.gov/pubmed/26986757 http://dx.doi.org/10.1371/journal.pone.0151857 |
_version_ | 1782421642862919680 |
---|---|
author | Yang, Shasha Deng, Huacong Zhang, Qunzhou Xie, Jing Zeng, Hui Jin, Xiaolong Ling, Zixi Shan, Qiaoyun Liu, Momo Ma, Yuefei Tang, Juan Wei, Qianping |
author_facet | Yang, Shasha Deng, Huacong Zhang, Qunzhou Xie, Jing Zeng, Hui Jin, Xiaolong Ling, Zixi Shan, Qiaoyun Liu, Momo Ma, Yuefei Tang, Juan Wei, Qianping |
author_sort | Yang, Shasha |
collection | PubMed |
description | Growth factor receptor-bound protein 10 (Grb10) is an adaptor protein that can negatively regulate the insulin-like growth factor 1 receptor (IGF-1R). The IGF1-1R pathway is critical for cell growth and apoptosis and has been implicated in kidney diseases; however, it is still unknown whether Grb10 expression is up-regulated and plays a role in diabetic nephropathy. Catalpol, a major active ingredient of a traditional Chinese medicine, Rehmannia, has been reported to possess anti-inflammatory and anti-aging activities and then used to treat diabetes. Herein, we aimed to assess the therapeutic effect of catalpol on a mouse model diabetic nephropathy and the potential role of Grb10 in the pathogenesis of this diabetes-associated complication. Our results showed that catalpol treatment improved diabetes-associated impaired renal functions and ameliorated pathological changes in kidneys of diabetic mice. We also found that Grb10 expression was significantly elevated in kidneys of diabetic mice as compared with that in non-diabetic mice, while treatment with catalpol significantly abrogated the elevated Grb10 expression in diabetic kidneys. On the contrary, IGF-1 mRNA levels and IGF-1R phosphorylation were significantly higher in kidneys of catalpol-treated diabetic mice than those in non-treated diabetic mice. Our results suggest that elevated Grb10 expression may play an important role in the pathogenesis of diabetic nephropathy through suppressing IGF-1/IGF-1R signaling pathway, which might be a potential molecular target of catalpol for the treatment of this diabetic complication. |
format | Online Article Text |
id | pubmed-4795681 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-47956812016-03-23 Amelioration of Diabetic Mouse Nephropathy by Catalpol Correlates with Down-Regulation of Grb10 Expression and Activation of Insulin-Like Growth Factor 1 / Insulin-Like Growth Factor 1 Receptor Signaling Yang, Shasha Deng, Huacong Zhang, Qunzhou Xie, Jing Zeng, Hui Jin, Xiaolong Ling, Zixi Shan, Qiaoyun Liu, Momo Ma, Yuefei Tang, Juan Wei, Qianping PLoS One Research Article Growth factor receptor-bound protein 10 (Grb10) is an adaptor protein that can negatively regulate the insulin-like growth factor 1 receptor (IGF-1R). The IGF1-1R pathway is critical for cell growth and apoptosis and has been implicated in kidney diseases; however, it is still unknown whether Grb10 expression is up-regulated and plays a role in diabetic nephropathy. Catalpol, a major active ingredient of a traditional Chinese medicine, Rehmannia, has been reported to possess anti-inflammatory and anti-aging activities and then used to treat diabetes. Herein, we aimed to assess the therapeutic effect of catalpol on a mouse model diabetic nephropathy and the potential role of Grb10 in the pathogenesis of this diabetes-associated complication. Our results showed that catalpol treatment improved diabetes-associated impaired renal functions and ameliorated pathological changes in kidneys of diabetic mice. We also found that Grb10 expression was significantly elevated in kidneys of diabetic mice as compared with that in non-diabetic mice, while treatment with catalpol significantly abrogated the elevated Grb10 expression in diabetic kidneys. On the contrary, IGF-1 mRNA levels and IGF-1R phosphorylation were significantly higher in kidneys of catalpol-treated diabetic mice than those in non-treated diabetic mice. Our results suggest that elevated Grb10 expression may play an important role in the pathogenesis of diabetic nephropathy through suppressing IGF-1/IGF-1R signaling pathway, which might be a potential molecular target of catalpol for the treatment of this diabetic complication. Public Library of Science 2016-03-17 /pmc/articles/PMC4795681/ /pubmed/26986757 http://dx.doi.org/10.1371/journal.pone.0151857 Text en © 2016 Yang et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Yang, Shasha Deng, Huacong Zhang, Qunzhou Xie, Jing Zeng, Hui Jin, Xiaolong Ling, Zixi Shan, Qiaoyun Liu, Momo Ma, Yuefei Tang, Juan Wei, Qianping Amelioration of Diabetic Mouse Nephropathy by Catalpol Correlates with Down-Regulation of Grb10 Expression and Activation of Insulin-Like Growth Factor 1 / Insulin-Like Growth Factor 1 Receptor Signaling |
title | Amelioration of Diabetic Mouse Nephropathy by Catalpol Correlates with Down-Regulation of Grb10 Expression and Activation of Insulin-Like Growth Factor 1 / Insulin-Like Growth Factor 1 Receptor Signaling |
title_full | Amelioration of Diabetic Mouse Nephropathy by Catalpol Correlates with Down-Regulation of Grb10 Expression and Activation of Insulin-Like Growth Factor 1 / Insulin-Like Growth Factor 1 Receptor Signaling |
title_fullStr | Amelioration of Diabetic Mouse Nephropathy by Catalpol Correlates with Down-Regulation of Grb10 Expression and Activation of Insulin-Like Growth Factor 1 / Insulin-Like Growth Factor 1 Receptor Signaling |
title_full_unstemmed | Amelioration of Diabetic Mouse Nephropathy by Catalpol Correlates with Down-Regulation of Grb10 Expression and Activation of Insulin-Like Growth Factor 1 / Insulin-Like Growth Factor 1 Receptor Signaling |
title_short | Amelioration of Diabetic Mouse Nephropathy by Catalpol Correlates with Down-Regulation of Grb10 Expression and Activation of Insulin-Like Growth Factor 1 / Insulin-Like Growth Factor 1 Receptor Signaling |
title_sort | amelioration of diabetic mouse nephropathy by catalpol correlates with down-regulation of grb10 expression and activation of insulin-like growth factor 1 / insulin-like growth factor 1 receptor signaling |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795681/ https://www.ncbi.nlm.nih.gov/pubmed/26986757 http://dx.doi.org/10.1371/journal.pone.0151857 |
work_keys_str_mv | AT yangshasha ameliorationofdiabeticmousenephropathybycatalpolcorrelateswithdownregulationofgrb10expressionandactivationofinsulinlikegrowthfactor1insulinlikegrowthfactor1receptorsignaling AT denghuacong ameliorationofdiabeticmousenephropathybycatalpolcorrelateswithdownregulationofgrb10expressionandactivationofinsulinlikegrowthfactor1insulinlikegrowthfactor1receptorsignaling AT zhangqunzhou ameliorationofdiabeticmousenephropathybycatalpolcorrelateswithdownregulationofgrb10expressionandactivationofinsulinlikegrowthfactor1insulinlikegrowthfactor1receptorsignaling AT xiejing ameliorationofdiabeticmousenephropathybycatalpolcorrelateswithdownregulationofgrb10expressionandactivationofinsulinlikegrowthfactor1insulinlikegrowthfactor1receptorsignaling AT zenghui ameliorationofdiabeticmousenephropathybycatalpolcorrelateswithdownregulationofgrb10expressionandactivationofinsulinlikegrowthfactor1insulinlikegrowthfactor1receptorsignaling AT jinxiaolong ameliorationofdiabeticmousenephropathybycatalpolcorrelateswithdownregulationofgrb10expressionandactivationofinsulinlikegrowthfactor1insulinlikegrowthfactor1receptorsignaling AT lingzixi ameliorationofdiabeticmousenephropathybycatalpolcorrelateswithdownregulationofgrb10expressionandactivationofinsulinlikegrowthfactor1insulinlikegrowthfactor1receptorsignaling AT shanqiaoyun ameliorationofdiabeticmousenephropathybycatalpolcorrelateswithdownregulationofgrb10expressionandactivationofinsulinlikegrowthfactor1insulinlikegrowthfactor1receptorsignaling AT liumomo ameliorationofdiabeticmousenephropathybycatalpolcorrelateswithdownregulationofgrb10expressionandactivationofinsulinlikegrowthfactor1insulinlikegrowthfactor1receptorsignaling AT mayuefei ameliorationofdiabeticmousenephropathybycatalpolcorrelateswithdownregulationofgrb10expressionandactivationofinsulinlikegrowthfactor1insulinlikegrowthfactor1receptorsignaling AT tangjuan ameliorationofdiabeticmousenephropathybycatalpolcorrelateswithdownregulationofgrb10expressionandactivationofinsulinlikegrowthfactor1insulinlikegrowthfactor1receptorsignaling AT weiqianping ameliorationofdiabeticmousenephropathybycatalpolcorrelateswithdownregulationofgrb10expressionandactivationofinsulinlikegrowthfactor1insulinlikegrowthfactor1receptorsignaling |